archive /

Forbion Secures €2.1 Billion for Biotech Innovation

2024-10-16

Belgian Biotech Secures $60M for GPCR Antibody Breakthroughs

2024-09-09

Confo Therapeutics Secures $60M for GPCR Antibody Research

2024-09-01

Belgian Biotech Confo Therapeutics Secures $60 Million for GPCR Drug Development

2024-08-16

CAR-T Therapy Trial Halted: Parkinsonism Raises Safety Concerns

2024-08-15

Confo Therapeutics Secures $60M to Advance GPCR Antibody Research

2024-08-02

Exscientia Acquires Full Rights to Promising Cancer Drug

2024-07-18

AI-Driven Biotech Ventures Secure $3.6 Billion Boost

2024-07-11